FULC β€” FULCRUM THERAPEUTICS INC

Ownership history in MACQUARIE GROUP LTD  Β·  2 quarters on record

This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in FULCRUM THERAPEUTICS INC (FULC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)    FULC price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,495 -1,870 -42.8% 0.00% $23K $9.20
2024 Q1 INITIATED 4,365 β€” β€” 0.00% $41 β€”

🏒 Other funds also holding FULC

As of 2025 Q4 β€” sorted by position size

GREAT POINT PARTNERS LLC 3Y 7Y 2.93% GSK plc 2.53% First Turn Management, LLC 2.45% TCG Crossover Management, LLC 3Y 1.97% Nantahala Capital Management, LLC 3Y 7Y 1.61% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.52% Ikarian Capital, LLC 3Y 1.21% BRAIDWELL LP 3Y 1.11% ADAR1 Capital Management, LLC 1.03% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.7%
← Back to MACQUARIE GROUP LTD Holdings